United States set
language
Menu Shopping cart $0 Search
Manufactured by BioVendor

SARS-CoV-2 Spike Glycoprotein Indian Mutation B.1.617, HEK293

  • Regulatory status:RUO
  • Type:Recombinant protein
  • Source:HEK293
  • Other names:Severe acute respiratory syndrome coronavirus 2 spike glycoprotein, 2019 novel coronavirus Spike protein, COVID-19
  • Species:SARS-CoV-2
Cat. No. Size Price


New RB978611100 0.1 mg
New RB9786111000 1.0 mg
PubMed Product Details
Technical Data

Type

Recombinant protein

Description

SARS-CoV-2 Spike glycoprotein, Indian Variant B.1.617. Active trimeric form. UniProt acc. no. P0DTC2. Full-length sequence aa 1 –1273. Mutations: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H. Further mutations: furin cleavage site RRAR modified to GSAG, K986P, V987P. C-terminal tag.

Source

HEK293

Formulation

Liquid in buffer 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG

Reconstitution

Defrost at ambient temperature.

Applications

Western blotting, ELISA, COVID-19, ligand binding assays

Shipping

On ice. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store protein at -80°C. Protein remains stable until the expiry date when stored at -80°C. Avoid repeated freezing/thawing cycles.

Note

This product is intended for research use only.

Summary

Research topic

COVID-19

Related Products Docs